Xeris Biopharma benefits from the FDA's CRL to Corcept's relacorilant, removing a major competitive threat to Recorlev sales ...
Test Performed on an Energized 138 kV, 63-mile Transmission Line HOUSTON, TX / ACCESS Newswire / March 4, 2026 / Camber Energy, Inc. (OTCQB:CEIN) ("Camber" or the "Company") today announced that its m ...
Morgan Stanley Technology, Media & Telecom Conference 2026 March 3, 2026 5:35 PM ESTCompany ParticipantsHong Hou - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results